Profound Medical Corp (PRN-T) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr03/2026	Next Qtr06/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$-0.33	$-0.34	$-1.32	$-1.11
Number of Estimates	3	3	3	3
High Estimate	$-0.31	$-0.30	$-1.08	$-0.37
Low Estimate	$-0.34	$-0.40	$-1.70	$-2.22
Prior Year	$-0.52	$-0.72	$-1.97	$-1.32
Growth Rate Est. (year over year)	+36.54%	+52.78%	+32.99%	+15.91%

Earnings History - Surprises*

	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025	Qtr Ending03/2025
Reported	$-0.38	$-0.36	$-0.72	$-0.52
Estimate	$-0.38	$-0.53	$-0.60	$-0.41
Difference	unch	+0.17	-0.12	-0.11
Surprise	unch	+32.08%	-20.00%	-26.83%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.75

3 Mths Ago4

4.75

2 Mths Ago4

4.75

1 Mth Ago4

4.75

Current4

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	4	4	4	4
	3 1	3 1	3 1	3 1
Holds	0	0	0	0

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Lululemon appoints long-time Nike executive Heidi O’Neill as new CEO

Bullish on Pembina Pipeline Corp.

How investors should digest the stock market’s ‘sugar high’

Market Factors: Top picks, sector review for income-heavy utilities sector

The most oversold and overbought stocks on the TSX

The highest-yielding stocks on the TSX, plus risk data

Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility

It’s not just Allbirds - another meme-stock season is on the horizon, Vanda Research says